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A B S T R A C T
Objective: Leishmania RNA virus (LRV) is a double-stranded RNA (dsRNA) virus that circulates within
many species of the Leishmania parasite. In this study, we aimed to investigate the presence of LRV2
circulating in Leishmania isolates in an old focus of ZCL located in northeastern of Iran.
Methods: Leishmania isolates were collected from 85 patients that confirmed to have cutaneous
leishmaniasis (CL) based on parasitological examination. To identify the Leishmania isolates, species-
specific primer sets were applied for molecular identification. The presence of LRV2 was performed by
RdRp-semi nested-PCR. The genetic diversity were calculated using MEGA and DnaSP. To assess
haplotype diversity, 31 LRV2 strains in different regions were surveyed using analysis a 292-bp section of
the RdRp sequences.
Results: Out of 85 patients, 83 (97.6 %) were diagnosed with L. major and 2 (2.4 %) with L. tropica. LRV2
virus was detected in 59 (69.4%) of the CL cases. For the first time, LRV2 was reported in one L. tropica
strain in Iran. The current LRV2 sequences indicated the highest similarities to an Old World LRV2.
Moreover, 10 unique haplotypes were identified based on the analyzed sequences of the RdRp gene.
Conclusions: Our results indicated the highest occurrence of Leishmania/LRV2 co-circulation in this
known ZCL focus from northeastern Iran. Phylogenetic analyses of LRV2 sequences confirmed that these
isolates belong to the order of LRV2 from the Old World. This study offered an insight into LRV2 haplotype
that the informative issue can be used for genetic research of LRV2 in other regions.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Leishmaniasis is a neglected vector-borne disease caused by an
intracellular protozoan parasite belonging to the genus Leishmania
spp. (Alvar et al., 2012). Clinical presentations include a broad
range of manifestations, ulcerative lesions of cutaneous leishman-
iasis (CL), Mucocutaneous Leishmaniasis (ML), and visceral
leishmaniasis (VL), also known as kala-azar (Desjeux, 2004). CL
is the dominant manifestation and widely distributed worldwide,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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350 million are at risk of acquiring the disease (WHO, 2018;
Steverding, 2017). According to the World Health Organization
(WHO), leishmaniasis is found in parts of the tropical and
subtropical regions of the Far and Middle East, Central, Western
and Eastern Europe and Africa as Old World leishmaniasis (OWL)
and in South and Central America as New World leishmaniasis
(NWL) (WHO, 2018; Steverding, 2017). It is found in about 98
countries, but approximately 95% of CL cases have occurred in
seven countries, including Afghanistan, Algeria, Brazil, Colombia,
Iran, Iraq and the Syrian Arab Republic (Reithinger et al., 2007). In
Iran, there are two forms of CL, zoonotic cutaneous leishmaniasis
(ZCL) caused by L. major and anthroponotic cutaneous leishmani-
asis (ACL) caused by L. tropica. ZCL is endemic mostly in the rural
and arid areas of about 80 percent of Iranian provinces (Ghatee
et al., 2020). Golestan Province is an endemic province of ZCL in
Iran, that the main causative agent of ZCL is L. major which is
transmitted mainly by the Phlebotomus papatasi Scopoli and also
the main reservoir host is Rhombomys opimus (Rassi et al. 2008;
Sharbatkhori et al. 2014). Previous studies have shown that the
incidence rate of ZCL has increased in the Golestan Province. In the
study conducted by Sofizadeh et al. the highest incidence rate of
the ZCL in Golestan Province were reported in Moraveh_Tappeh
(121.5/100000) and Gonbad Kavoos (99.3/100000) respectively
(Sofizadeh et al., 2016).
Almost three decades ago, the first Leishmania virus, also known
as Leishmania RNA virus (LRV), was introduced in L. guyanensis
(Tarr et al., 1988). LRVs are classified in the Totiviridae family
composed of about 5.3 kb double-stranded RNA (dsRNA) genome,
RNA-dependent RNA polymerase (RdRp) and capsid protein (Stuart
et al.,1992). This virus particles are icosahedral (T = pseudo 2), non-
enveloped, and approximately 30-50 nm in diameter (Stuart et al.,
1992). According to the complete nucleotide sequences, LRVs were
divided into two major groups: LRV1 infecting New World
Leishmania (NWL) isolates such as L. (Viannia) braziliensis and L.
guyanensis and LRV2 were identified in isolates from Old World
Leishmania (OWL) such as L. major. (Scheffter et al., 1995; Saiz et al.,
1998). Based on their phylogeny analysis, the complete nucleotide
sequence of the RNA-dependent RNA polymerase (RdRp) gene
indicates high diversity between LRV1 and LRV2 (less than 40%
homology) (Scheffter et al., 1995).Figure 1. Representative images of map of the study area locations in GIn recent years, most studies focus on the topic of Leishmania
RNA virus 1, because it is believed that it can increase parasite
replication, pathology, and metastatic of lesions (Adaui et al.,
2015). It was demonstrated that dsRNA of LRV interacts with Toll-
like receptor 3 (TLR3), and induces pro-inflammatory cytokines
and chemokines such as (interferon-β, TNF- α, CXCL10, CCL5, and
IL-6) and subverts innate immunity. It, in turn, leading to a
hyperinflammatory response to Leishmania infection (Hartley
et al., 2012). However, the mechanisms that contribute to parasite
persistence and increased disease remain largely undiscovered.
Previous evidence about the presence of LRV2 in Leishmania spp.
isolates collected from Iran persuaded our study. The purpose of this
current study was to determine the presence of LRV2 and its genetic
diversity in Leishmania isolates , which circulated in the Golestan
Province, as a known old focus of ZCL in the northeast of Iran.
Subjects and Methods
Ethical statement
This study was approved by the ethical principles and the
national norms and standards for conducting Medical Research in
Iran for the molecular identification of Leishmania RNA virus 2
(LRV2) in Leishmania parasites isolated from CL patients (IR.
MAZUMS.REC.1398.344). Informed written consent was obtained
according to guidelines from the adult subjects and from the
children’s parents and their written explanations were recorded
using a structured questionnaire.
Study area
This study was conducted in Golestan Province with a
population of about 1.9 million people covers the area of 20438
km2 located in the northeast of Iran. It has a border of 348 km with
Turkmenistan and is one of the known old foci of ZCL. Recent
studies have been shown that the incidence of ZCL cases has
increased in the last decade in the Golestan Province. The
Leishmania parasites were collected from the patients before
treatment who were suspected of CL have been referred to the
referral health centers laboratory in Golestan Province, between
















































8 R. Saberi et al. / International Journal of Infectious Diseases 101 (2020) 6–13Samples collection
The dermal lesions were sterilized with 70% ethanol, and
sample collection was done by scrapping the swollen edge of the
lesions. The exudate materials were initially cultured on a Novy-
MacNeal-Nicolle medium (NNN) medium. After 3-5 days, pro-
mastigotes were then transferred to RPMI 1640 medium (Gibco,
Life Technologies GmbH, Germany) with 10% heat-inactivated fetal
bovine serum (Gibco, Germany), 100 U/mL penicillin, and 100 mg/
mL streptomycin (Gibco, German), and incubated at 26 C.
Identification of Leishmania species by PCR-RFLP
The DNA of Leishmania was prepared using the Bioneer kit
(Bioneer Company, Korea) according to the manufacturer’s
instructions. To amplify a fragment of approximate 1450–60 bp
of the N-acetyl glucosamine-1-phosphate transferase (NAGT) gene
in Leishmania genus parasites, specific primers Forward (5' TCA
TGA CTC TTG GCC TGG TAG 3') and Reverse (5' CTC TAG CGC ACT
TCA TCG TAG 3') were used (Saberi et al., 2018). The isolates studied
were identified by PCRRFLP analysis and Acetylcoenzyme A
carboxylase 1 (ACC1) (Xmil) enzyme (Fermentas GmbH, Thermo
Scientific, Germany) that it can provide different digestion patterns
for different species of Leishmania spp.
Viral double-strand RNA extraction
1  106 stationary phase promastigotes were collected by
sedimentation, and for the extraction of viral dsRNA, 2 ml of lysis
buffer [1 ml Tris-HCl (pH 8.0) and 10 % sodium dodecyl sulfate (SDS)]
containing 100 mg/mL of proteinase K were added to the sediment of
Leishmania promastigotes. The lysates were incubated at 37 C, for
45 min. The lysates are then mixed with phenol, and centrifuged at
3000 rpm for 15 min. Carefully removal of the top aqueous solution,
adds an equal volume of the ether, and centrifuged at 3000 rpm for 5
min. Removal as much of the top ether solution as possible and
precipitated with 0.15 M NaCl in 70% ethanol, then washed and re-
suspended in TNE buffer (100 mM NaCl,1 mM EDTA (pH = 8),10 mM
Tris (pH = 7.4). Viral dsRNA bands were visualized on 0.8% agarose
gel after DNase I enzyme (Fermentas, Life Sciences) treatment
according to the manufacturer’s instructions (Hajjaran et al., 2016).
RNA extraction and synthesis of cDNA
Total RNA from 1-5  106 promastigotes in the stationary phase
was isolated according to the manufacturer’s instructions (Favor-
gen RNA extraction kit, Favorgen Biotech). Isolated RNA was
resuspended in 60 mL of nuclease-free water. The quantity of the
extracted RNAs was verified by a NanoDrop spectrometer (Thermo
Scientific Fisher, USA). Based on the quantity of the extracted RNA,
1 to 2 mL were used for cDNA synthesis. The cDNA was then
synthesized with a combination of oligo (dT) 18 and random
hexamer primers using the cDNA Synthesis Kit (YTA, Iran with Cat
No: YT4500) according to the manufacturer’s instructions.
Semi-nested PCR
Semi-nested PCR assays for detection of LRV-2 were performed
with set primers for the first stage LRV F1 (5' TGT AAC CCA CAT AAA
CAG TGT GC 3') and LRV R (5'ATT TCA TCC AGC TTG ACT GGG 3') that
amplified a 526-bp external partial sequence of the RdRp gene. To
amplify the 315-bp internal fragment of the RdRp gene, specific
primers LRV F2 (5' AGG ACA ATC CAA TAG GTC GTG T 3') and LRV R
primers were used (Hajjaran et al., 2016). The PCR amplification
was carried out in a 25 mL PCR reaction mixture consisting12.5 mL
of master mix (Ampliqon, Denmark), 10 pmol each of forward andbackward primers, and 1 mL of cDNA. The final volume was mad
25 ml by the addition of nuclease-free water.
The PCR conditions for the semi-nested PCR in both stage
consisted of initial denaturation of DNA strands at 94 C for 5 mi
followed by 35 cycles of denaturation at 94 C for 35 s, prime
annealing at 60 C for 35 s and strand elongation at 72 C for 45 s. 
final extension of the strands was made at 72 C for 5 min. The PC
products were confirmed by visualization on 1.2% agarose ge
stained with SYBR safe gel stain (Thermo Fisher Scientific, USA) fo
visualization of corresponding size PCR products. Standar
reference strains of LRV 2 [LRV2/IR/2014/HM-2 (Acc. No
KP054245)] were used as positive controls.
Sequencing, phylogenetic analysis and haplotype network
PCR products of the RdRp gene related to 15 unique LRV
isolates were purified and sequenced using an ABI PrismTM 373
Genetic Analyzer (Applied Biosystems, Foster City, California, USA
by the Macrogen Company (Seoul, South Korea). Multiple align
ments of viral sequences were performed using BioEdit, versio
7.0.5 and examined using the program Mega 7 .0.7. To estimat
phylogenetic trees for the LRV data sets we selected the maximum
likelihood (ML) methods using Kimura 2-parameter models i
MEGA 7 .0.7. In addition, bootstrap resampling analysis (1,00
replications) was used to assess branch confidence in clades i
each tree (Kumar et al., 2016). Five LRV1 samples including L. (V
guyanensis and L. (V.) braziliensis were also added to th
phylogenetic analysis for comparison. Furthermore, Trichomona
vaginalis virus (TVV) was used as outgroup to construct th
phylogenetic tree. The number of segregating sites, diversit
indices (Haplotype diversity and Nucleotide diversity) an
neutrality indices (Tajima’s D and Fu’s Fs tests) were estimate
by DnaSP software version 5.10 (Rozas et al., 2003). A network o
LRV2 haplotypes based on the sequences of RdRp was drawn b
PopART software version 7.1 (Bandelt et al., 1999).
Results
Identification of Leishmania isolates based on the nagt-PCR-RFLP
Leishmania DNA was detected in all 85 isolates obtained from C
patients and amplification of LeishmaniaDNA exhibited a singl
1450–60 bp fragment of the N-acetyl glucosamine-1-phosphat
transferase (nagt) gene, which was consistent with the product siz
of Leishmania genus. Digestion with the ACC1 enzyme produce
two bands of 500 and 950 bp for L. major and two bands of 680 an
780 bp for L. tropica, respectively. Based on the ACC1 enzym
digestion pattern , 83 out of 85 isolates obtained from CL patient
were identified as L. major and 2 as L. tropica.
Detection of LRV2 in Leishmania isolatesbased on the RdRp-semi-
nested PCR
Based on the amplification of the 526-bp and 315-bp product
in the first and second rounds of RdRp-semi-nested PCR, 59 of 8
(69.4 %) clinical cultures were LRV2 positive and 26 were LRV
negative. LRV2 was detected in 58/83 cases of L. major and 1/
cases of L. tropica infections. It should be noted, the LRV2- L. tropic
isolate was first reported in Iran. The presence of LRV2 wa
confirmed using a dsRNA extraction, which recognizes specificall
a distinct band of about 5.3 kb indicative of viral dsRNA (Figure 2
Phylogenetic characteristics and haplotype diversity of LRV2 isolate
Sequencing of the 15 unique samples carried out by Sange
sequencing method and sequences were deposited to GenBan
Figure 2. Visualization of viral dsRNA by gel electrophoresis. M: 1 kb ladder marker,
Line 1: Positive control of LRV2 (LRV2/IR/2014/HM-2), Lines 2–7: Samples of LRV2
positive (current study), Line 8: Negative control of LRV 2 (MRHO/IR/11/GOL-2),
Line 9: Sample of LRV2 negative (current study).
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MT268295). Sequences were 95-99 % similar to the partial
sequence LRV2 isolated from Iran, Turkey, Ethiopia and complete
genome LRV2 isolate from Uzbekistan and Turkmenistan (Figure
3). The intra-species difference was observed among the current
RdRp sequences isolates (LRV2) and the overall mean distance
between present isolates was calculated to be 0.022. Among LRV2Figure 3. Phylogenetic tree of RdRp gene sequences of Leishmania RNA virus from CL pa
from GenBank.sequences in this study, high differences were observed between
the isolate of LRV2/IR/GOL/711 with isolates of LRV2/IR/GOL/715
and LRV2/IR/GOL/720 (0.0636) (Table 1).
To determine haplotype diversity, LRV2 sequences from this
study with other OWL ones from Iran (n = 3), Turkey (n = 10),
Uzbekistan (n = 2) and Turkmenistan (n = 1) were analyzed. In
current study, 10 haplotypes were reported but totally, 19
haplotypes of LRV2 were identified that 16 haplotypes in LRV2-
L.major, 2 haplotypes in LRV2- L.tropica and 1 haplotype in LRV2- L.
infantum (Table 2). The minimum spanning network was
conducted in order to discern a genealogical relationship among
the haplotypes (Figure 4). The MK246759.1 was the most common
haplotype (n = 7) in the population network that belong to LRV2-L.
tropica strains. The diversity and neutrality indices were calculated
based on the RdRp gene sequences (Table 3). In the 19 haplotypes
of LRV2, the relative high haplotype diversity belonged to LRV2-L.
major (Hd: 0.957), while haplotype diversity for LRV2-L. tropica and
LRV2-L. infantum were (Hd: 0.250 and Hd: 0), respectively.
Nucleotide diversity was ranging from 0.02602 for LRV2- L. major
to 0.00514 for LRV2-L. tropica and 0 for LRV2-L. infantum. Negative
values were observed for both Fu’s Fs test and Tajima’s D test for
sequences from LRV2-L. major and LRV2-L. tropica (Table 3).
Discussion
CL is an endemic parasitic disease in Iran, in which two types of
CL including ACL and ZCL occur in 25 of the 31 Iranian provinces
(Ghatee et al., 2020; Yaghoobi-Ershadi et al., 2004). Golestan
Province is one of the oldest ZCL foci in Iran, which has a border
with Turkmenistan (Sofizadeh et al., 2016). In recent years, ZCL
cases have been reported increasingly from different areas of
















Diversity between the current LRV2 based on the RdRp gene.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 LRV2/IR/GOL/935
2 LRV2/IR/GOL/864 0.0220
3 LRV2/IR/GOL/1025 0.0223 0.0306
4 LRV2/IR/GOL/1034 0.0182 0.0035 0.0264
5 LRV2/IR/GOL/977 0.0035 0.0259 0.0261 0.0219
6 LRV2/IR/GOL/546 0.0107 0.0257 0.0342 0.0297 0.0144
7 LRV2/IR/GOL/645 0.0000 0.0220 0.0223 0.0182 0.0035 0.0107
8 LRV2/IR/GOL/607 0.0182 0.0035 0.0264 0.0000 0.0219 0.0297 0.0182
9 LRV2/IR/GOL/694 0.0107 0.0183 0.0109 0.0145 0.0143 0.0218 0.0107 0.0145
10 LRV2/IR/GOL/702 0.0182 0.0035 0.0264 0.0000 0.0219 0.0297 0.0182 0.0000 0.0145
11 LRV2/IR/GOL/705 0.0182 0.0035 0.0264 0.0000 0.0219 0.0297 0.0182 0.0000 0.0145 0.0000
12 LRV2/IR/GOL/709 0.0000 0.0220 0.0223 0.0182 0.0035 0.0107 0.0000 0.0182 0.0107 0.0182 0.0182
13 LRV2/IR/GOL/711 0.0499 0.0593 0.0600 0.0547 0.0541 0.0544 0.0499 0.0547 0.0458 0.0547 0.0547 0.0499
14 LRV2/IR/GOL/715 0.0259 0.0035 0.0346 0.0071 0.0297 0.0295 0.0259 0.0071 0.0220 0.0071 0.0071 0.0259 0.0636
15 LRV2/IR/GOL/720 0.0259 0.0108 0.0346 0.0071 0.0297 0.0378 0.0259 0.0071 0.0220 0.0071 0.0071 0.0259 0.0636 0.0145
*Differences between isolate of LRV2/IR/GOL/711(13) with isolate LRV2/IR/GOL/715 (14) is 0.0636.
Table 2
Haplotype, isolates, country and host of Leishmania RNA virus 2, using the RNA dependent RNA polymerase (RdRp) sequences.
Haplotype Haplotype. no Isolates Country Host Ref.
Hap_1 3 LRV2/IR/GOL/935 Iran L. major This study
LRV2/IR/GOL/645 Iran L. major This study
LRV2/IR/GOL/709 Iran L. major This study
Hap_2 1 LRV2/IR/GOL/864 Iran L. major This study
Hap_3 1 LRV2/IR/GOL/1025 Iran L. major This study
Hap_4 4 LRV2/IR/GOL/1034 Iran L. major This study
LRV2/IR/GOL/607 Iran L. major This study
LRV2/IR/GOL/702 Iran L. major This study
LRV2/IR/GOL/705 Iran L. major This study
Hap_5 1 LRV2/IR/GOL/977 Iran L. tropica This study
Hap_6 1 LRV2/IR/GOL/546 Iran L. major This study
Hap_7 1 LRV2/IR/GOL/694 Iran L. major This study
Hap_8 1 LRV2/IR/GOL/711 Iran L. major This study
Hap_9 1 LRV2/IR/GOL/715 Iran L. major This study
Hap_10 1 LRV2/IR/GOL/720 Iran L. major This study
Hap_11 1 KP054244.1 Iran L. infantum Hajjaran et al. (2016)
Hap_12 1 MK246762.1 Turkey L. major Nalçacı et al. (2019)
Hap_13 1 MK246761.1 Turkey L. major Nalçacı et al. (2019)
Hap_14 1 MK246760.1 Turkey L. major Nalçacı et al. (2019)
Hap_15 1 KP054245.1 Iran L. major Hajjaran et al. (2016)
Hap_16 7 MK246759.1 Turkey L. tropica Nalçacı et al. (2019)
MK246758.1 Turkey L. tropica Nalçacı et al. (2019)
MK246757.1 Turkey L. tropica Nalçacı et al. (2019)
MK246756.1 Turkey L. tropica Nalçacı et al. (2019)
MK246755.1 Turkey L. tropica Nalçacı et al. (2019)
MK246754.1 Turkey L. tropica Nalçacı et al. (2019)
MK246753.1 Turkey L. tropica Nalçacı et al. (2019)
Hap_17 1 MN013357.1 Iran L. major Hajjaran et al. (2016)
Hap_18 2 MN418975.1 Uzbekistan L. major Kleschenko et al. (2019)
MN418974.1 Uzbekistan L. major Kleschenko et al. (2019)
Hap_19 1 U32108.1 Turkmenistan L. major Scheffter et al. (1995)
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Province (during 2010 to 2017 years) was indicated an increasing
trend in the number of cases from the region (Jorjani et al., 2019).
The first presence of LRV2 was reported from L. major in
Turkmenistan in 1995 (Scheffter et al., 1995). In addition, previous
evidence research the presence of LRV2 in Iran (Hajjaran et al.,
2016). Hence, to the best of knowledge, this is the first haplotype
and phylogenetic based study on the LRV2 strains from CL patients
in a known ZCL focus in Iran.
We surveyed 85 samples of L. major and L. tropica isolated from
infected patients, out of the 85 isolates, 59 samples were LRV2
positive. This study represents the first report of LRV2 in L.tropicain
Iran and the second report of LRV2 in L. major, following the
Hajjaran et al.’s study (Hajjaran et al., 2016). There is no
comprehensive and epidemiological study in the OWL regionregarding LRV2 in Leishmania spp., isolates. However, a stud
reported the presence of LRV2 in L. aethiopica human isolates i
Ethiopia, in which 5 out of 11 L. aethiopica isolates were LRV
positive (Zangger et al., 2014). In the study conducted by Hajjaran
out of 50 Leishmania isolated from CL and VL patients in differen
parts of Iran, only two isolates, L. major and L. infantum isolate
were LRV2 positive (Hajjaran et al., 2016). Furthermore, investigat
the presence of LRV2 in Leishmania species from Turkey indicate
7of the 24 L. tropica and 3 of the 3 L. major isolates were LRV
positive (Nalçacı et al., 2019). In a recently published article, tw
isolates of LRV2 detected in 3 L. major isolates from human patient
with CL in south Uzbekistan (Kleschenko et al., 2019). Considerin
the fact that the first LRV2 described in L. major species from
Turkmenistan, and recent studies showed a high presence of th
LRV2 was also detected among L. major species. Thus, it seems tha
Figure 4. RNA-dependent RNA polymerase sequences (RdRp) haplotype networks in LRV2 from different geographical foci of Old World leishmaniasis.
Table 3
The diversity and neutrality indices of LRV2 populations from different species of Old World leishmaniasis based on RdRp gene.
Species Diversity parameters Neutrality indices
n Hn Parsimony informative sites Singleton variable sites (Hd) (Nd) Tajima’s D Fu’s Fs statistic
L. major 22 16 21 20 0.957 0.02643 1.22659 4.278
L. tropica 8 2 0 6 0.250 0.00514 1.63982 2.822
L. infantum 1 1 N.A. N.A. 0.000 0.00000 N.A. N.A.
* Hn: number of haplotypes; Hd: haplotype diversity; Nd: nucleotide diversity; N.A.: Not available.
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consistent with the findings of our study.
In the meta-analysis study conducted by Saberi and colleagues,
the global prevalence of LRVs was estimated to be 26.2%, which
ranged from 10 % in Peru, to 70% in Brazil, and 74% in the French
Guiana (Saberi et al., 2019). The results of these experiments
indicated the 69.4 % (59/85) of Leishmania isolates were LRV2
positive. This difference might be attributed to the fact that the
geographical origin of the Leishmania isolates. In this study, we
report the high presence of LRV2 in Golestan Province, different
factors could be regarded as the reasons, including tropical climate
conditions, ecologic and epidemiologic aspects, and population
movement to Turkmenistan for trade (Ghatee et al., 2019). These
topic support the hypothesis that for the first time the LRV2 have
entered Iran from Turkmenistan. In order to support this
hypothesis, the partial sequence of the LRV2 isolates using BLASTn
analysis revealed that 95-97% similarity to LRV2 from L.major in
Turkmenistan (Acc. No: U32108.1). In addition, phylogenetic
analysis, ecological changes and weather condition, common
borders with Turkmenistan can support in this hypothesis. It
should be noted that further studies such as whole genome
sequencing of LRV2 and determination of its genetic map are
needed to prove the hypothesis.
In the next step, the isolates were identified as LRV2 by
phylogenetic analysis based on the RdRp sequence, an approach
proven to be useful for the molecular characterization of LRV 2
(Hajjaran et al., 2016). Moreover, the phylogenetic analysis of
current LRV2 sequences was similar to those of LRV2 reference
isolates from OWL species (Iran, Turkey, Turkmenistan, Uzbeki-
stan and Ethiopia) (Hajjaran et al., 2016; Nalçacı et al., 2019;
Scheffter et al., 1995; Kleschenko et al., 2019; Zangger et al., 2014).From a phylogenetic perspective, the LRVs sequences in the
phylogenetic tree can be grouped distinctly into two main
clusters, one containing the LRV 1 sequences while the other LRV2
sequences, as we expected. Interestingly, the current sequence of
RdRp gene showed several different nucleotides in distinct LRV2
isolates. This phenomenon revealed the genetic variation of the
LRV2 genome (Scheffter et al., 1995). In the previous studies, the
LRV1 type is divided into 14 subtypes (LRV1-1 to LRV1-14) (Tarr
et al., 1988; Guilbride et al., 1992; Widmer et al., 1989).
Interestingly, the LRV1-1 and LRV1-4 sequences share 77% overall
nucleotide identity between themselves (Scheffter et al., 1995),
representing genetic variation of the LRV, which is consistent
with the findings of the current study (Table 1). Another study
conducted in Uzbekistan reported the complete sequence of two
Leishmania RNA Virus 2 found in L. major isolated from patients
with CL. Results from this study showed that 170 nucleotide /40
amino acid and 174 nucleotide/41 amino acid differences between
Uzb1/ASKH and Uzb2/ASKH sequences, respectively (Kleschenko
et al., 2019). Moreover, this result was in consistent to that of Tirera
et al, which indicated that 24 LRV1 full-length coding sequences
presenting among themselves a significant genetic diversity
(Tirera et al., 2017). Based on the findings of aboved-mentioned
studies, it seems that the genetic diversity in the RdRp gene is
relatively high.
The haplotype diversity value based on RdRp sequences
revealed the degree of diversity within the LRV2 isolates. Relative
high levels of haplotype and nucleotide diversity were observed in
LRV2-L. major and this population expansion was evident from Fu’s
Fs test for LRV2-L. major sequences, where a negative Tajima’s D
test implies purifying selection. Indeed, a recent population
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selection. On the other hand, positive Fs value observed in LRV2-L.
tropica sequences are suggestive of a recent population bottleneck.
The fact that current LRV2 populations shared 10 haplotypes,
which probable is these haplotypes emerged in different regions
and spread into Golestan Province. The high number of haplotypes
reported in this study is probably due to genetic diversity among
the isolates in this study. However, more extensive sampling and
more in-depth molecular studies in other regions are needed to
confirm this assumption.
A relative high value of haplotype diversity among LRV2-L.
major may be involved in exacerbating of L. major pathogenicity
including the creation of metastatic lesions, parasite replication,
and developing treatment failure in clinical isolates. To this end, we
have conducted a study for this topic and its results will be
published in the future.
In recent study, conducted by Atayde et al. finding indicated
that a LRV spreads by exploiting a mechanism used for cell-to-cell
connection, a discovery that could introduce the way to new
vaccines against severe form of the disease. In above-mentioned
study, these researchers state that LRV1 hides in tiny vessels,
known as exosomes pathway. In future, the use of Leishmania
exosomes containing the LRV could proposed as new vaccine
candidate against leishmaniasis (Atayde et al., 2019).
Conclusion
This study is the first report on the presence of LRV2 in Golestan
Province and it is the second one in Iran. We have developed a
sensitive method to evaluate the presence of LRV2 in Leishmania
positive clinical samples. To conclude, the high prevalence of
Leishmania strains infected with LRV2, displaying the capability of
Leishmania spp. to establish an endosymbiotic relationship with
the Leishmania RNA virus simultaneously. The present study aligns
with previous reports in that haplotype diversity exists between
populations of this LRV2 strains. Leishmania isolates obtained from
this study were from the patients confirmed with CL in Golestan
Province, thus, the finding of this study may not be generalizable to
other populations or other geographic areas of the Iran and
neighboring countries.
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